`
`Drugs@FDk FDA Approved Drug Products
`
`Drugs@FDA: FDA Approved Drug
`Products
`
`f SHARE H'|'I'PS:llWWW.FACEBOOK.COMlSHARERISHARER.PHP?U=H1'|'P:lIWWW.ACCESSDATA.FDA.GOVISCR|PTSlCDERlDAFIlNDEX.CFM?
`EVENT=OVERVlEW.PROCESS&APPLNO=021023
`
`’ TWEET H'|'|'PS:I/TWl'I'|'ER.COMIlNTENTITWEETI’?TEXT=DRUGS FDA: FDA APPROVED DRUG
`fi?ODUCTS&URL=H'|'I'P:IIWWW.ACCESSDATA.FDA.GOVISCRIPTSICDE RlDAFIINDEX.CFM ?EVE NT=OVE RVIEW.PROCESS&APPLNO=021 023
`
`+ !
`
`EMAIL (MAILTO:?SUBJECT=DRUGS@FDA: FDA APPROVED DRUG
`PRODUCTS&BODY=HTTP:IlWWW.ACCESSDATA.FDA.GOV/SCRIPTSICDERIDAF/INDEX.CFM?EVENT=OVERVIEW.PROCESS&APPLNO=021023
`
`Home (index.cfm1 | Previous Page
`
`New Drug Application (NDA): 021023
`Company: ALLERGAN
`Drug Name(s):
`
`- RESTASIS (CYCLOSPORINE)
`
`a EMAIL MAILTO:?SUBJECT=DRUGS FDA: FDAAPPROVED DRUG
`PRODUCTS&BODY=H'|'|'P:lIWWW.ACCESSDATA.FDA.GOVlSCR| PTSICDERIDAFIINDEX.CFM ?EVENT=OVERVlEW.PROCESS%26VARAPPLNO=021023)
`
`Products on NDA 021023
`
`A roval Date s and Histor Letters Labels Reviews for NDA 021023
`
`v
`
`A
`
`Original Approvals or Tentative Approvals
`
`CSVExcelPrint
`
`Action
`Date
`
`Action
`Submission Type
`
`Submission
`Classification
`
`10/10/2003 ORIG-1
`
`Approval
`
`Type 3 - New
`Dosage Form
`
`Review
`
`Priority;
`Orphan
`Status
`
`Letters, Reviews, Labels, Patient Package lnse
`
`PRIORITY Review (http://www.accessdata.fda.gov/drugsatfc
`
`htlp://www.accessdata.fda.gov/scripts/oder/daffi ndex.cfm ?event=overview.process&App|No=021023
`
`1/2
`
`1
`
`ALL 2032
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01130
`
`1
`
`ALL 2032
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01130
`
`
`
`3/16/2017
`
`Drugs@FDA: FDA Approved Drug Products
`
`
`
`httpj/www.accessdata.fda.govlscriplslcder/daffi ndex.cfm ?event=overview.process&App|No=021023
`2
`
`2/2
`
`2
`
`